Mauritius vs Syrian Arab Republic: HIV-positive TB patients on ART (antiretroviral therapy)
Mauritius
100.0%
in 2024
Syrian Arab Republic
100.0%
in 2021
Mauritius rank
1st
Syrian Arab Republic rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Mauritius
- Syrian Arab Republic
How they compare
Mauritius currently reports 100.0% against 100.0% in Syrian Arab Republic, a difference of 0.0%.
Across all 11 years both countries report, Syrian Arab Republic has been ahead every year.
Mauritius ranks 1st and Syrian Arab Republic ranks 1st of 144 countries.
Syrian Arab Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mauritius | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.0% | 100.0% | 14.0% | Syrian Arab Republic |
| 2010s | 85.9% | 100.0% | 14.1% | Syrian Arab Republic |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Mauritius or Syrian Arab Republic?
- Mauritius, at 100.0% against 100.0% in Syrian Arab Republic as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Mauritius and Syrian Arab Republic?
- 0.0%, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and Syrian Arab Republic?
- 11 years are reported by both, from 2007 to 2021.
- How do Mauritius and Syrian Arab Republic rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Mauritius ranks 1st and Syrian Arab Republic ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.